NIIMBL Releases First Industry-wide Biomanufacturing Readiness Level Framework
NEWARK, Del., September 29, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces a Biomanufacturing Readiness Levels (BRLs) framework to lay the groundwork for a universal assessment of technology maturity and readiness level for commercial biomanufacturing technology…
$3M from NIST for Equipment to Support Advancements in Biopharma Manufacturing
NEWARK, Del., September 13, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) along with the University of Delaware are pleased to announce $3M in Congressionally-directed funding from the National Institute of Standards and Technology (NIST) for new equipment which will support the advancement of biopharmaceutical manufacturing processes and provide expanded opportunities for workforce development.
NIIMBL Announces $15.8M to Fund 14 New Biopharmaceutical Manufacturing Projects
NEWARK, Del., August 9, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $15.8M in planned project activities through the Institute’s Project Call 5.2 for 14 new projects in technology and workforce development that will help to address key opportunities for innovation in the biopharmaceutical industry.
NIIMBL Welcomes Alok Patel
Newark, Del., May 17, 2022 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Alok Patel has recently joined the Institute as Assistant Director, Business Development and Strategic Initiatives. In this role Mr. Patel will strengthen NIIMBL’s emphasis on regional economic and workforce development.
NIIMBL eXperience Program Returns In Person with New 2022 Cohort
Newark, Del., April 5, 2021 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has selected seven students for their 2022 NIIMBL eXperience Program. This year, the NIIMBL eXperience Program returns in person and offers real-world insight into career options in the biopharmaceutical industry for African American/Black, Latinx, and Native American college freshman and sophomore students from Historically Black Colleges and Universities (HBCUs), and NIIMBL member institutions.
NIIMBL Welcomes New Senior Fellow Dr. Juan Torres
Newark, Del., February 8, 2022 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Dr. Juan Torres has recently joined the Institute as a NIIMBL Senior Fellow and will be leading the Quality team for a next generation factory concept design project within the NIIMBL-led Process Intensification (PI) Program.
NIIMBL Announces a New Faculty Sabbatical Program for Educators in Higher Ed
Newark, Del., January 18, 2022— Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced the NIIMBL Faculty Fellows Program, a pilot program that will provide financial support for faculty and instructional staff at universities and community colleges to pursue a sabbatical with NIIMBL industry member organizations or directly with NIIMBL.
NIIMBL Announces 32 Projects Funded Under the American Rescue Plan
Newark, Del., December 20, 2021— Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan (ARP).
NIIMBL Welcomes 4 Senior Fellows
Newark, Del., October 26, 2021 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Jeffery Baker, Ph.D., Tim Charlebois, Ph.D., Roger Hart, Ph.D., and Stefanie Pluschkell, Ph.D. have recently joined the Institute as NIIMBL Senior Fellows enhancing that expertise of the organization with an additional 100 years of industry experience.
NIIMBL Announces $3M to Fund 6 New Biopharmaceutical Manufacturing Projects
NEWARK, Del., October 5, 2021 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $3M in funding for 6 new projects in technology specifically aimed to support the NIIMBL non-profit and academic member community through the Institute’s Project Call 5.1.
NIIMBL eXperience Program Leads to Student Internships
This summer, a group of talented students received a jump start on a career in the biopharmaceutical industry during the NIIMBL eXperience.
Building on the success of previous years, NIIMBL held its third eXperience from June 14 – 25, 2021. This program gives African American/Black, Latinx and Native American college freshmen and sophomores an inside track into the world of biopharmaceuticals. The goal is to provide students with career options that they may not have otherwise considered and help the industry connect with and inspire up-and-coming talent.
New Collaboration Aims to Improve Measurement of Viral Vectors
New Collaboration Aims to Improve Measurement of Viral Vectors Used in Cutting-Edge Gene Therapies
A large interlaboratory study of adeno-associated virus (AAV), an important tool in gene therapy, will be led by USP and NIST in collaboration with NIIMBL.